Diabetes conference defies COVID-19 to set new attendance record

News /  / 
A delegate asks a question at ATTD 2020 A delegate asks a question at ATTD 2020

Some good news for a change.

While other conferences were being cancelled due to the coronavirus outbreak, the 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020) was busy breaking attendance records.

The meeting took place 19-22 February, in Madrid, Spain, bringing together more than 3,800 healthcare professionals from 81 countries - a conference record.

Organisers Kenes Group had monitored the situation since early January and held regular meetings with chairs Professor Moshe Phillip and Professor Tadej Battelino, to discuss the situation.

A plan was put in place to keep delegates informed about the outbreak and its effects on the host destination, including any travel information, and advice from the World Health Organization (WHO) advice on staying healthy while travelling.

Anti-bacterial gel and face masks were given to delegates. And for registered participants in China who were unable to travel, a significant part of the conference was live-streamed.

“At the ATTD Conferences you can meet people that come because they want to contribute and be part of the ATTD Community that really moves things forward and strives to make a significant change for the lives of people with diabetes”, said Prof. Tadej Battelino, conference co-chair.

Ori Lahav, VP clients & operations at Kenes Group, said: “It is a challenge to organise international meetings in times of a growing epidemic such as COVID-19. However, we have to remember that staying calm, analysing the situation and the risks, is of key importance.

“We need to keep on providing healthcare professionals platforms to meet for finding solutions to pertinent problems of our society, such as diabetes, as there are over 400 million diagnosed around the world, according to WHO. We are very proud to work with outstanding professionals as Professor Moshe Phillip and Professor Tadej Battelino, who gave us all their trust to continue forward with the meeting, only to create the best one to date.”

The ATTD aims to improve and harmonise the treatment for patients with diabetes by providing medical education to healthcare professionals and by offering best practice approaches. The 14th edition of the meeting will take place in Paris, France, 17-20 February 2021.

James Lancaster
Written By
James Lancaster

AMI editor James Lancaster is a familiar face in the meetings industry and international association community. Since joining AMI in 2010, he has gained a reputation for asking difficult questions and getting lost in convention centres. Proofer, podcaster, and panellist - in his spare time, James likes to walk, read, listen to music, and drink beer.

Latest Magazine

AMI November 2022 Covershot
Soaraway Inflation
How to plan your next meeting
Read More